HomeICCC • NASDAQ
add
ImmuCell Corp
Previous close
$6.35
Day range
$6.25 - $6.55
Year range
$4.52 - $7.60
Market cap
58.26M USD
Avg Volume
12.45K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 7.63M | -1.61% |
Operating expense | 2.17M | -1.90% |
Net income | -2.85M | -653.71% |
Net profit margin | -37.36 | -662.65% |
Earnings per share | — | — |
EBITDA | 1.45M | 11.82% |
Effective tax rate | -0.12% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.81M | 1.29% |
Total assets | 42.53M | -5.69% |
Total liabilities | 15.48M | -11.97% |
Total equity | 27.06M | — |
Shares outstanding | 9.05M | — |
Price to book | 2.12 | — |
Return on assets | 4.20% | — |
Return on capital | 4.43% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.85M | -653.71% |
Cash from operations | 482.54K | 15,915.83% |
Cash from investing | -167.31K | 14.73% |
Cash from financing | -394.60K | -365.07% |
Net change in cash | -79.37K | -57.47% |
Free cash flow | 798.29K | 317.44% |
About
Founded
1982
Headquarters
Website
Employees
81
